MaxCyte Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Revenue	41.29	44.26	33.89	26.17	21.62
Revenue Growth (YoY)	-6.72%	30.59%	29.52%	21.04%	-
Cost of Revenue	4.74	5.1	3.65	2.77	2.5
Gross Profit	36.55	39.16	30.25	23.4	19.12
Selling, General & Admin	57.04	44.48	31.68	15.7	13.41
Research & Development	23.82	19.51	15.41	17.73	17.59
Other Operating Expenses	3.99	2.53	1.35	1.03	0.54
Operating Expenses	84.85	66.52	48.44	34.46	31.54
Operating Income	-48.3	-27.36	-18.19	-11.06	-12.42
Interest Expense / Income	0	0	1.04	0.83	0.68
Other Expense / Income	-10.38	-3.79	-0.15	-0.07	-0.21
Pretax Income	-37.92	-23.57	-19.08	-11.82	-12.9
Net Income	-37.92	-23.57	-19.08	-11.82	-12.9
Shares Outstanding (Basic)	103	102	91	69	56
Shares Outstanding (Diluted)	103	102	91	69	56
Shares Change	1.54%	12.23%	30.45%	23.17%	-
EPS (Basic)	-0.37	-0.23	-0.21	-0.17	-0.23
EPS (Diluted)	-0.37	-0.23	-0.21	-0.17	-0.23
Free Cash Flow	-25.38	-33.26	-14.51	-10.85	-10.07
Free Cash Flow Per Share	-0.25	-0.33	-0.16	-0.16	-0.18
Gross Margin	88.51%	88.48%	89.24%	89.43%	88.44%
Operating Margin	-116.98%	-61.82%	-53.66%	-42.25%	-57.44%
Profit Margin	-91.85%	-53.25%	-56.30%	-45.15%	-59.64%
Free Cash Flow Margin	-61.46%	-75.15%	-42.81%	-41.48%	-46.59%
EBITDA	-33.36	-20.11	-16.61	-9.94	-11.6
EBITDA Margin	-80.79%	-45.43%	-49.02%	-38.00%	-53.65%
Depreciation & Amortization	4.57	3.47	1.42	1.05	0.61
EBIT	-37.92	-23.57	-18.04	-10.99	-12.21
EBIT Margin	-91.85%	-53.25%	-53.22%	-42.00%	-56.49%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).